Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

ts 2 years of age and older. Further studies are being performed to determine the long-term benefits and risks of Exjade.

Exjade is contraindicated in patients with hypersensitivity to deferasirox or to any other component of Exjade.

Cases of acute renal failure, some with a fatal outcome, have been reported following the post-marketing use of Exjade. Most of the fatalities occurred in patients with multiple comorbidities and who were in advanced stages of their hematologic disorders. There have also been reports of renal tubulopathy in patients treated with Exjade. Give particular attention to monitoring serum creatinine in patients who: are at increased risk of complications, have pre-existing renal conditions, are elderly, have comorbid conditions, or are receiving medicinal products that depress renal function.

Assess serum creatinine in duplicate before initiating therapy to establish a reliable pretreatment baseline, due to variations in measurements. Monitor serum creatinine monthly thereafter. In patients with additional renal risk factors (those who are at increased risk of complications, have pre-existing renal conditions, are elderly, have comorbid conditions, or are receiving medicinal products that depress renal function), monitor serum creatinine weekly during the first month after initiation or modification of therapy and monthly thereafter. Nonprogressive increases in serum creatinine have been noted in 38% of Exjade-treated patients, compared to 14% of deferoxamine-treated patients in Study 1 and 36% vs 22%, respectively in Study 3, and appear to be dose related. These increases were within the normal range in 94% of patients. Exjade dosages were adjusted when serum creatinine elevations were detected during the study.

Consider dose reduction, interruption, or discontinuation for elevations in serum creatinine. For adult patients, reduce daily dose of Exjade by 10
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CVS/pharmacy and MinuteClinic health care centers ... H1N1 vaccine in 20 states and Washington, D.C. ... receiving H1N1 vaccines continue, many states have lifted ... receive the shot while supplies last. In ... is available at MinuteClinic locations across the country ...
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... Dec. 16 Naurex Inc., a new ... and other CNS disorders based on its novel ... has initiated a Phase I clinical trial of ... the first subjects in the study. GLYX-13, ... modulator of the NMDA receptor, is initially being ...
Breaking Medicine Technology:CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 1DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 2DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 3PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 1PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 2PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 3New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 1New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 2New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 3
... May 30 (ASX: PGL;,Nasdaq: PGLA) New ... will,be presented tomorrow at the American Association ... by Progen,s collaborators at the Johns,Hopkins University., ... that compounds in Progen,s,existing preclinical cancer epigenetics ...
... Epeius Biotechnologies,( http://www.epeiusbiotech.com ) announced today the results ... metastatic bone and soft tissue sarcoma (J,Clin Oncol ... so far only targeted,gene therapy vector that has ... this open label study, cohorts of 6 to ...
Other Medicine Technology:Presentation of Data on Progen's Cancer Epigenetic Targets Platform 2Presentation of Data on Progen's Cancer Epigenetic Targets Platform 3Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008) 2
(Date:12/17/2009)... Howell, CEO of Arrayit Diagnostics, Inc., a ... Board: ARYC), today formally commented on the ... OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood ... development - the rights to which have ... Arrayit Corporation. ,, Howell stated, "In response ...
(Date:12/17/2009)... Simple interface and communications functions were determining factors. StaffKnex, ... recently announced it was selected by Lifespace Communities to ... , ... Cleveland, ... ), developers of web-based nurse scheduling and employee communication ...
(Date:12/17/2009)... Analysis reports, activity measures and outcomes reporting to monitor the ... claim costs and positive return on investment over the course ... ... Jacksonville, FL (PRWEB) December 17, 2009 -- HealthScreen Disease ... based cost risk analysis along with personalized nurse care, announced ...
(Date:12/16/2009)... Health care sector revenue increased by ... from $1.66 trillion in 2007, according to new ... is classified under the North American Industry Classification ... ) ,, These figures come from the ... Assistance , a series of tables which provides ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
Breaking Medicine News(10 mins):Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3
... N.Y., March 6 The national Tourette,Syndrome Association, Inc. ... House of Representatives approving The Mental Health Parity,Act by ... Wellstone Mental Health,and Addiction Equity Act (H.R. 1424), the ... part of health insurance packages equal,to the coverage in ...
... are tougher on replaced joints, study finds , , THURSDAY, March ... knee replacement surgeries each year may want to put away ... new study shows. , Biking and treadmill walking appear to ... had a knee replaced with an artificial joint, researchers found, ...
... Nonprofits Receive the GlaxoSmithKline 11th Annual IMPACT ... (NYSE:,GSK), one of the world,s leading research-based ... of the GlaxoSmithKline,11th Annual IMPACT Awards. Nonprofits ... in unrestricted funding. They include the Center ...
... IRVING, Texas, March 6 An Arlington, Texas,based ... 66 defendants in a,federal fraud lawsuit filed Thursday in ... people involved in automobile accidents at,clinics in Texas, Ohio, ... suit in the U.S. District Court,for the Northern District ...
... all soaps are alike - Dial ... Complete(R) is different., SCOTTSDALE, Ariz., March 6 ... illness. As a,matter of fact, people wash their hands an average of ... or equipment. This raises the,question of whether all soaps work equally well ...
... 6 In testimony before a,joint session of the ... John Rowan both praised and damned Congress for actions,taken ... enacted, could make a,huge difference in the lives of ... for the significant increases in,appropriations for veterans health care ...
Other Medicine News:Health News:Tourette Syndrome Association Celebrates the House Passage of LONG-AWAITED Mental Health Parity Legislation 2Health News:Biking, Walking Best for New Knees 2Health News:Biking, Walking Best for New Knees 3Health News:GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding 2Health News:GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding 3Health News:Alleged Multi-Million Dollar Fraud Ring Target of Federal Lawsuit 2Health News:Alleged Multi-Million Dollar Fraud Ring Target of Federal Lawsuit 3Health News:Does Antibacterial Soap Work? At Least One Really Does. 2Health News:VVA Calls for $5 Billion More for Health Care and Better Outreach 2
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Long Reach Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Binding, Graduated, Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
Medicine Products: